Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Evans, BEW"'
Autor:
Saunders, MJ, Wingfield, T, Datta, S, Montoya, R, Ramos, E, Baldwin, MR, Tovar, MA, Evans, BEW, Gilman, RH, Evans, CA
Background The epidemiological impact and cost-effectiveness of social protection and biomedical interventions for tuberculosis-affected households might be improved by risk stratification. We therefore derived and externally validated a household-le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::513c0631a688b639cf81b9aa65ac6f1a
http://hdl.handle.net/10044/1/83880
http://hdl.handle.net/10044/1/83880
Autor:
Saunders MJ; Department of Infectious Diseases, Imperial College London, London, UK; Innovation For Health And Development, Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru; Innovación Por la Salud Y Desarrollo, Asociación Benéfica PRISMA, Lima, Peru. Electronic address: matthew.saunders@ifhad.org., Wingfield T; Innovation For Health And Development, Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru; Innovación Por la Salud Y Desarrollo, Asociación Benéfica PRISMA, Lima, Peru; Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, UK; LIV-TB Collaboration and Department of Clinical Science, Liverpool School of Tropical Medicine, Liverpool, UK; Social Medicine, Infectious Diseases and Migration Group, Department of Public Health Sciences, Karolinska Institute, Stockholm, Sweden., Datta S; Department of Infectious Diseases, Imperial College London, London, UK; Innovation For Health And Development, Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru; Innovación Por la Salud Y Desarrollo, Asociación Benéfica PRISMA, Lima, Peru., Montoya R; Innovation For Health And Development, Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru; Innovación Por la Salud Y Desarrollo, Asociación Benéfica PRISMA, Lima, Peru., Ramos E; Innovation For Health And Development, Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru; Innovación Por la Salud Y Desarrollo, Asociación Benéfica PRISMA, Lima, Peru., Baldwin MR; Innovation For Health And Development, Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru; Innovación Por la Salud Y Desarrollo, Asociación Benéfica PRISMA, Lima, Peru; College of Physicians and Surgeons, Columbia University, New York, NY, USA., Tovar MA; Innovation For Health And Development, Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru; Innovación Por la Salud Y Desarrollo, Asociación Benéfica PRISMA, Lima, Peru., Evans BEW; Innovation For Health And Development, Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru., Gilman RH; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Evans CA; Department of Infectious Diseases, Imperial College London, London, UK; Innovation For Health And Development, Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru; Innovación Por la Salud Y Desarrollo, Asociación Benéfica PRISMA, Lima, Peru.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2020 Jan; Vol. 20 (1), pp. 110-122. Date of Electronic Publication: 2019 Oct 31.
Autor:
Saunders MJ; Infectious Diseases and Immunity, Imperial College London, London, UK.; Wellcome Trust Imperial College Centre for Global Health Research, London, UK.; Innovation For Health And Development (IFHAD), Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru.; Innovación Por la Salud Y Desarrollo (IPSYD), Asociación Benéfica PRISMA, Lima, Peru., Tovar MA; Infectious Diseases and Immunity, Imperial College London, London, UK.; Wellcome Trust Imperial College Centre for Global Health Research, London, UK.; Innovation For Health And Development (IFHAD), Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru.; Innovación Por la Salud Y Desarrollo (IPSYD), Asociación Benéfica PRISMA, Lima, Peru., Datta S; Infectious Diseases and Immunity, Imperial College London, London, UK.; Wellcome Trust Imperial College Centre for Global Health Research, London, UK.; Innovation For Health And Development (IFHAD), Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru.; Innovación Por la Salud Y Desarrollo (IPSYD), Asociación Benéfica PRISMA, Lima, Peru., Evans BEW; Innovation For Health And Development (IFHAD), Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru.; Innovación Por la Salud Y Desarrollo (IPSYD), Asociación Benéfica PRISMA, Lima, Peru., Wingfield T; Innovación Por la Salud Y Desarrollo (IPSYD), Asociación Benéfica PRISMA, Lima, Peru.; Clinical Infection, Microbiology, and Immunity, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.; Social Medicine, Infectious Diseases and Migration Group, Dept of Public Health Science, Karolinksa Institutet, Stockholm, Sweden.; LIV-TB, Liverpool School of Tropical Medicine, Liverpool, UK., Evans CA; Infectious Diseases and Immunity, Imperial College London, London, UK.; Wellcome Trust Imperial College Centre for Global Health Research, London, UK.; Innovation For Health And Development (IFHAD), Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru.; Innovación Por la Salud Y Desarrollo (IPSYD), Asociación Benéfica PRISMA, Lima, Peru.
Publikováno v:
The European respiratory journal [Eur Respir J] 2018 Mar 22; Vol. 51 (3). Date of Electronic Publication: 2018 Mar 22 (Print Publication: 2018).